Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
Physical Therapy Research|May 13, 2021
Minimum standards of clinical practice for physical therapists working in intensive care units in JapanTetsuya Takahashi, Michitaka Kato, Kengo Obata, et al.Digestive Diseases (Basel, Switzerland)|May 26, 2023
Safety of Cold Snare Polypectomy during Continuous Use of Antithrombotic Drugs for Delayed Post-Polypectomy Bleeding: A Pilot StudyJunnosuke Hayasaka, Satoshi Yamashita, Akira Matsui, et al.ESC Heart Failure|January 27, 2025
Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in JapanTakanori Naito, Kazufumi Nakamura, Yukio Abe, et al.Digestive Diseases and Sciences|August 4, 2023
Diagnostic Performance of Endoscopic Ultrasonography with Water-Filled Balloon Method for Superficial Esophageal Squamous Cell CarcinomaYugo Suzuki, Kosuke Nomura, Daisuke Kikuchi, et al.Journal of Human Genetics|January 20, 2017
Genome-wide association study using the ethnicity-specific Japonica array: identification of new susceptibility loci for cold medicine-related Stevens-Johnson syndrome with severe ocular complicationsMayumi Ueta, Hiromi Sawai, Ryosei Shingaki, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|September 5, 2017
Effect of Intensive and Standard Pitavastatin Treatment With or Without Eicosapentaenoic Acid on Progression of Coronary Artery Calcification Over 12 Months - Prospective Multicenter StudyToru Miyoshi, Kunihisa Kohno, Hirohiko Asonuma, et al.Journal of Clinical Medicine|September 10, 2021
Post-Intensive Care Syndrome and Its New Challenges in Coronavirus Disease 2019 (COVID-19) Pandemic: A Review of Recent Advances and PerspectivesNobuto Nakanishi, Keibun Liu, Daisuke Kawakami, et al.Journal of Cardiology|June 15, 2015
Clinical characteristics of responders to treatment with tolvaptan in patients with acute decompensated heart failure: Importance of preserved kidney sizeHironobu Toda, Kazufumi Nakamura, Makoto Nakahama, et al.Scientific Reports|September 14, 2022
Effects of luseogliflozin and voglibose on high-risk lipid profiles and inflammatory markers in diabetes patients with heart failureKentaro Ejiri, Toru Miyoshi, Hajime Kihara, et al.Journal of the American Heart Association|August 18, 2020
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes MellitusKentaro Ejiri, Toru Miyoshi, Hajime Kihara, et al.Pageof 9